Siemens Healthineers AG

SHL

Company Profile

  • Business description

    Siemens Healthineers is engaged in therapeutic imaging, radiotherapy, laboratory, and point-of-care diagnostics. The imaging segment (55% of sales in fiscal 2024) includes magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound. The Varian segment (17% of sales) offers radiotherapy and other oncology solutions. The portfolio of the diagnostics segment (20%) includes in vitro diagnostics products offered to providers and point-of-care diagnostics. The advanced therapies segment (9%) products are designed to support image-guided minimally invasive treatments in cardiology, interventional radiology, and surgery. Americas represents 42% of total sales, Europe, Middle East, and Africa 33%, and Asia-Pacific including China the remainder.

  • Contact

    Siemensstrasse 3
    ForchheimBY91301
    DEU

    T: +49 9131843385

    https://www.siemens-healthineers.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    30 September 2025

    Employees

    73,000

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,021.9060.200.76%
CAC 407,285.8644.11-0.60%
DAX 4021,205.86105.16-0.49%
Dow JONES (US)39,142.23527.16-1.33%
FTSE 1008,275.660.060.00%
HKSE21,395.14338.161.61%
NASDAQ16,286.4520.71-0.13%
Nikkei 22534,627.11249.510.73%
NZX 50 Index12,118.9951.070.42%
S&P 5005,282.707.000.13%
S&P/ASX 2007,819.1060.200.78%
SSE Composite Index3,280.344.340.13%

Market Movers